Himension Capital Singapore PTE. LTD. Acquires New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Himension Capital Singapore PTE. LTD. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, Holdings Channel reports. The firm purchased 6,528 shares of the healthcare conglomerate’s stock, valued at approximately $3,302,000.

Several other hedge funds have also added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $32,000. Finally, Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Wells Fargo & Company lowered their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $524.94 on Friday. The firm has a market capitalization of $480.17 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. The stock’s 50 day moving average is $509.24 and its 200-day moving average is $542.12. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.